| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 01/30/2014 | US20140031368 Selective hdac inhibitors |
| 01/30/2014 | US20140031290 Novel glp-1 receptor stabilizers and modulators |
| 01/29/2014 | EP2688864A1 Insecticidal compounds |
| 01/29/2014 | CN102603559B Phenylacetyl fluorobenzene salicylamide compound and application thereof |
| 01/28/2014 | US8636996 Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate |
| 01/23/2014 | WO2014015235A2 3,5,n-trihydroxy-alkanamide and derivatives: method for making same and use thereof |
| 01/23/2014 | WO2014013512A1 Improved process for preparation of 2,3-dihydroxy benzonitrile |
| 01/23/2014 | WO2014012832A1 Process for the preparation of 2-(3-n,n-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol and its derivatives |
| 01/23/2014 | US20140024852 Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto |
| 01/22/2014 | CN103524372A Novel histone deacetylase inhibitor |
| 01/22/2014 | CN102757379B Preparation method of alvimopan |
| 01/22/2014 | CN102070482B Derivatives of natural product S6-2, and preparation method and use thereof as anti-tumor medicines |
| 01/16/2014 | WO2014009964A1 Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide |
| 01/16/2014 | WO2014009767A1 An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers and salts |
| 01/16/2014 | WO2014009027A1 Lipase-stable thickening agent |
| 01/16/2014 | DE102012212085A1 Lipase stabiler Verdicker Lipase stable thickener |
| 01/15/2014 | EP2684863A1 Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct |
| 01/15/2014 | EP2684861A2 Spiro compounds and pharmaceutical use thereof |
| 01/15/2014 | CN103508923A Preparation method for hindered phenol antioxidant |
| 01/15/2014 | CN103508919A Alkaloid compound and use of the same in preparation of anti-complement drugs |
| 01/15/2014 | CN103508912A Method for separation and preparation of spermidines from safflower by employing high-speed counter-current chromatography |
| 01/15/2014 | CN102807504B Method for synthesizing salicylamide |
| 01/14/2014 | US8629185 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof |
| 01/09/2014 | WO2014008159A1 Selective estrogen receptor degraders for treatment of tamoxifen resistant tumors |
| 01/09/2014 | US20140011785 Locally active "soft" antiandrogens |
| 01/08/2014 | EP2682382A2 Method for Producing Phenylacetamide Compound |
| 01/08/2014 | CN103497114A NMDA receptor antagonists for neuroprotection |
| 01/07/2014 | CA2560922C Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| 01/02/2014 | US20140005351 Novel compounds, method for preparation thereof and use thereof for preparing polymers useful for increasing heat resistance of polymeric compositions |
| 01/02/2014 | US20140005263 Treating androgen decline in aging male (adam)-associated conditions with sarms |
| 12/31/2013 | US8618316 Low temperature ramp rate ester quat formation process |
| 12/31/2013 | CA2534298C Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 12/27/2013 | WO2013190482A1 Resorcinol derivatives and their cosmetic application |
| 12/27/2013 | WO2013189930A1 Process for depigmenting keratin materials using novel resorcinol-based compounds |
| 12/26/2013 | US20130345470 Purification of 3-Hydroxypropionic Acid from Crude Cell Broth and Production of Acrylamide |
| 12/25/2013 | CN103467225A Method for preparing 1,4-dicarbonyl derivative |
| 12/25/2013 | CN101835737B Spiro-ring compound and use thereof for medical purposes |
| 12/24/2013 | US8614251 Crystalline form VI of agomelatine, preparation method and application thereof |
| 12/19/2013 | WO2013188882A1 Macromolecules for treating atherosclerosis |
| 12/19/2013 | WO2013187480A1 Novel cyclic depsipeptide derivative and pest control agent comprising same |
| 12/19/2013 | WO2013186153A2 Amidophenoxypropanolamines |
| 12/19/2013 | WO2013185928A1 Method for the preparation of 1-aryl-1-alkyl-2-alkyl-3-dialkylaminopropane compounds |
| 12/19/2013 | US20130338160 Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof |
| 12/19/2013 | US20130336892 Chimeric t1r taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric t1r polypeptides |
| 12/19/2013 | CA2876387A1 Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same |
| 12/18/2013 | EP2674414A1 Method for the preparation of 1-aryl-1-alkyl-3-dialkylaminopropane compounds |
| 12/18/2013 | CN103450077A IRE-1A inhibitors |
| 12/18/2013 | CN103450065A Preparation method of ezetimibe |
| 12/18/2013 | CN101903337B Antitumoral compounds |
| 12/18/2013 | CN101857554B Cinamic compounds and derivatives therefrom for inhibition of histone deacetylase |
| 12/17/2013 | US8609892 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/17/2013 | US8609733 Sensory-specific local anesthesia and prolonged duration local anesthesia |
| 12/12/2013 | WO2013185116A1 Lipids for therapeutic agent delivery formulations |
| 12/12/2013 | WO2013182993A1 Method for preparing nitrogen compounds |
| 12/12/2013 | US20130331328 Small molecule inhibitors of agbl2 |
| 12/12/2013 | CA2876148A1 Lipids for therapeutic agent delivery formulations |
| 12/11/2013 | CN103443068A Insecticidal compounds |
| 12/11/2013 | CN103443066A Ingenol-3-acylates I |
| 12/11/2013 | CN103435512A Method for preparing kukoamine B |
| 12/11/2013 | CN103435511A Synthetic method for N, N-disubstituted-2-hydroxyl aliphatic amide compound |
| 12/11/2013 | CN102304056B 3-methyl-4-aryl-3-alkenyl-butyryl-pentafluoroaniline derivatives and preparation method thereof |
| 12/11/2013 | CN102180809B Salicylamide ether compounds of pleuromutilin and preparation method thereof |
| 12/11/2013 | CN102015626B 4-trimethylammonio-butyrates as CPT2 inhibitors |
| 12/10/2013 | US8604229 Lipoxin analogs and methods for the treatment of periodontal disease |
| 12/10/2013 | US8604083 Method for the treatment of metabolic disorders |
| 12/10/2013 | CA2656851C Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 12/10/2013 | CA2556940C Modulator |
| 12/10/2013 | CA2555115C New crystalline form v of agomelatine, process for its preparation and pharmaceutical compositions containing it |
| 12/10/2013 | CA2552317C Hcv ns-3 serine protease inhibitors |
| 12/05/2013 | WO2013181451A1 Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarate |
| 12/05/2013 | WO2013178575A1 New indanyloxyphenylcyclopropanecarb oxylic acids |
| 12/05/2013 | US20130324555 Method of use of pharmaceutical formulations for the treatment of apicomplexan diseases in animals |
| 12/05/2013 | US20130324514 Indanyloxyphenylcyclopropanecarboxylic acids |
| 12/04/2013 | CN102432494B Novel chemical total synthesis preparation method for coronalon |
| 12/04/2013 | CN102229543B Extraction method for purified coronatine (COR) from fermentation liquor |
| 12/04/2013 | CN102134203B Beta-alkyloxy propionamide, solvent, detergent and liquid drug composition and preparation method of beta-alkyloxy propionamide |
| 12/04/2013 | CN102119142B Salicylamide derivatives as nicotinic alpha 7 modulators |
| 12/03/2013 | CA2755650C Process for the preparation of triiodinated carboxylic aromatic derivatives |
| 12/03/2013 | CA2530302C Novel aminobenzophenone compounds |
| 12/03/2013 | CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 11/28/2013 | WO2013174916A1 Indane dimers for use in the treatment of autoimmune inflammatory disease |
| 11/28/2013 | US20130317102 Novel Esters of (Acyloxymethyl)Acrylamide, a Pharmaceutical Composition Containing Them, and Their use as Inhibitors of the Thioredoxin - Thioredoxin Reductase System |
| 11/27/2013 | EP2666765A2 Process for the preparation of substituted 3-(1-amino-2-methyl-pentane-3-yl)phenyl compounds |
| 11/27/2013 | CN203303676U Metalaxyl production rectifying tower |
| 11/27/2013 | CN103415501A Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct |
| 11/27/2013 | CN103408452A Green synthesis process for p-chloro-o-nitroacetoanilide |
| 11/27/2013 | CN103408451A Kukoamine preparation method |
| 11/27/2013 | CN102617391B Resveratrol benzene acrylamide derivative, preparing method and application thereof |
| 11/21/2013 | US20130310351 Treating Long QT Syndrome |
| 11/20/2013 | EP2220029B1 Benzamide compounds and their use as prostaglandin E4 receptor agonists |
| 11/20/2013 | EP2014643B1 Para-methoxyaniline derivatives increasing the antiknock rating of hydrocarbon fuels and compositions based thereon |
| 11/20/2013 | CN103402975A Beta-hydroxyalkyl amide and resin composition |
| 11/19/2013 | US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease |
| 11/19/2013 | CA2603030C Benzyloxypropylamine derivative |
| 11/14/2013 | WO2013170165A1 Antibacterial agents |
| 11/14/2013 | US20130303761 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction |
| 11/14/2013 | US20130303444 Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid |
| 11/13/2013 | EP2662352A2 Method for Producing Phenylacetamide Compound |
| 11/13/2013 | CN103387509A Preparation method of HCV protease inhibitor intermediate |
| 11/12/2013 | CA2575029C Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions |